In Vivo Confocal Microscopy Demonstrates Increased Immune Cell Densities in Corneal Graft Rejection Correlating With Signs and Symptoms

2019 ◽  
Vol 203 ◽  
pp. 26-36 ◽  
Author(s):  
Chareenun Chirapapaisan ◽  
Alessandro Abbouda ◽  
Arsia Jamali ◽  
Rodrigo T. Müller ◽  
Bernardo M. Cavalcanti ◽  
...  
2022 ◽  
pp. 110-117
Author(s):  
D. A. Krakhmaleva ◽  
Z. V. Surnina ◽  
S. A. Malzhoen ◽  
A. A. Gamidov

Introduction. Corneal transplantation is the most successful and commonly performed allotransplantation procedure as compared with other organs and tissues. Over 100,000 corneal transplantations are performed worldwide every year.Purpose. This study investigated whether in vivo confocal microscopy (IVCM) can aid in the diagnosis of a graft rejection reaction by detecting changes in cellular structures and density of immune cells after penetrating keratoplasty.Materials and methods. The study included thirty-four eyes of 34 patients who underwent penetrating keratoplasty (7 eyes with corneal graft rejection, 27 without rejection). The average age of patients is 51.1 ± 13.6 years (from 23 to 76 years). The follow-up period ranged from 12 to 36 months (24.5 ± 4.84 months). Follow-up was performed at 1, 3, 6, 12 months and annually after PKP. To study the morphology of the cornea all patients underwent IVCM to assess the basal epithelium, subbasal layer, stroma and endothelium. Immune cells were identified and evaluated for the shape, length of the processes and their density.Results. Patients with corneal graft rejection demonstrated significant accumulation of corneal dendritic-like immune cells compared to patients with non-rejected grafts. In addition, the cells acquired a more mature morphology (grade 2–3). The density of dendritic cells (DC) was 809.17 ± 342.19 (p < 0.001). A positive correlation was found between DC density and graft rejection (p < 0.001). As well the patients showed signs of endothelial failure with low endothelial cell density and pleomorphism, increased light scattering and hyperreflectivity of the stroma.Conclusions. In a complex of diagnostic measures, confocal microscopy may provide a valuable clinical adjunctive tool in diagnosis and management of early corneal graft rejection.


Cornea ◽  
2015 ◽  
Vol 34 ◽  
pp. S61-S64 ◽  
Author(s):  
Viridiana Kocaba ◽  
Caterina Colica ◽  
Muriel Rabilloud ◽  
Carole Burillon

Cornea ◽  
2006 ◽  
Vol 25 (7) ◽  
pp. 761-768 ◽  
Author(s):  
Maria João Quadrado ◽  
Monika Popper ◽  
António Miguel Morgado ◽  
Joaquim Neto Murta ◽  
Jaap A Van Best

2006 ◽  
Vol 34 (8) ◽  
pp. 808-810 ◽  
Author(s):  
Claudio Traversi ◽  
Gianluca Martone ◽  
Alex Malandrini ◽  
Gian Marco Tosi ◽  
Aldo Caporossi

2017 ◽  
Vol 178 ◽  
pp. 27-37 ◽  
Author(s):  
Mohamed Abou Shousha ◽  
Sonia H. Yoo ◽  
Mohamed S. Sayed ◽  
Sean Edelstein ◽  
Matthew Council ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Jeremy Chung Bo Chiang ◽  
David Goldstein ◽  
Azadeh Tavakoli ◽  
Terry Trinh ◽  
Jacob Klisser ◽  
...  

AbstractImmune cell infiltration has been implicated in neurotoxic chemotherapy for cancer treatment. However, our understanding of immune processes is still incomplete and current methods of observing immune cells are time consuming or invasive. Corneal dendritic cells are potent antigen-presenting cells and can be imaged with in-vivo corneal confocal microscopy. Corneal dendritic cell densities and nerve parameters in patients treated with neurotoxic chemotherapy were investigated. Patients treated for cancer with oxaliplatin (n = 39) or paclitaxel (n = 48), 3 to 24 months prior to assessment were recruited along with 40 healthy controls. Immature (ImDC), mature (MDC) and total dendritic cell densities (TotalDC), and corneal nerve parameters were analyzed from in-vivo corneal confocal microscopy images. ImDC was increased in the oxaliplatin group (Median, Md = 22.7 cells/mm2) compared to healthy controls (Md = 10.1 cells/mm2, p = 0.001), but not in the paclitaxel group (Md = 10.6 cells/mm2). ImDC was also associated with higher oxaliplatin cumulative dose (r = 0.33, p = 0.04) and treatment cycles (r = 0.40, p = 0.01). There was no significant difference in MDC between the three groups (p > 0.05). Corneal nerve parameters were reduced in both oxaliplatin and paclitaxel groups compared to healthy controls (p < 0.05). There is evidence of elevation of corneal ImDC in oxaliplatin-treated patients. Further investigation is required to explore this potential link through longitudinal studies and animal or laboratory-based immunohistochemical research.


Cornea ◽  
1995 ◽  
Vol 14 (5) ◽  
pp. 467???472 ◽  
Author(s):  
Roberto A. Cohen ◽  
Sek J. Chew ◽  
Bryan M. Gebhardt ◽  
Roger W. Beuerman ◽  
Herbert E. Kaufman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document